Surgical Prophylaxis and Other Complication Avoidance Care Bundles

Surgical Clinics of North America

Volumn 92, Issue 2, 2012, Pages 285-305

  Schwulst, Steven J ^a   Mazuski, John E ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bundle; Quality; Standardization; Surgical site infection

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; CORTICOSTEROID; DROTRECOGIN; FLUDROCORTISONE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCORTISONE; LACTIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SUCRALFATE; VANCOMYCIN;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY PRESSURE; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ANTISEPSIS; APACHE; ARTIFICIAL VENTILATION; CATHETER INFECTION; CENTRAL VENOUS PRESSURE; CRYSTALLOID; DEEP VEIN THROMBOSIS; EVIDENCE BASED MEDICINE; EXTUBATION; GLOVE; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; HYPERLACTATEMIA; INFECTION RISK; MORTALITY; OVERALL SURVIVAL; PERSONAL HYGIENE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SEDATION; SEPSIS; SEPTIC SHOCK; STOMACH CONTENT; STOMACH HEMORRHAGE; STOMACH ULCER; SUBCLAVIAN VEIN; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL RISK; VENTILATED PATIENT; VENTILATOR ASSOCIATED PNEUMONIA;

ANTIBIOTIC PROPHYLAXIS; HUMANS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; QUALITY ASSURANCE, HEALTH CARE; SURGICAL WOUND INFECTION;

EID: 84858132377     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2012.01.011     Document Type: Review

References (124)

1. Marwick C., Davey P. Care bundles: the holy grail of infectious risk management in hospital?. Curr Opin Infect Dis 2009, 22:364-369.
2. Medicare program: changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates. Fed Regist 2007, 72:47379-47428.
3. Hansen S., Schwab F., Asensio A., et al. Methicillin-resistant Staphylococcus aureus (MRSA) in Europe: which infection control measures are taken?. Infection 2010, 38:159-164.
4. Byrnes M., Schuerer D., Schallom M., et al. Implementation of a mandatory checklist of protocols and objectives improves compliance with a wide range of evidence-based intensive care unit procedures. Crit Care Med 2009, 37:2775-2781.
5. Berenholtz S., Dorman T., Ngo K., et al. Qualitative review of intensive care unit quality indicators. J Crit Care 2002, 17:1-12.
6. Dodek P., Keenan S., Cook D., et al. Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med 2004, 141:305-313.
7. Fulbrook P., Mooney S. Care bundles in critical care: a practical approach to evidence-based practice. Nurs Crit Care 2003, 8:249-255.
8. Berwick D. Continuous improvement as an ideal in health care. N Engl J Med 1989, 320:53-56.
9. Sundin-Huard D. Subject positions theory: its application to understanding collaboration (and confrontation) in critical care. J Adv Nurs 2001, 34:376-382.
10. Rello J., Ollendorf D., Oster G., et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002, 122:2115-2121.
11. Warren D., Shukla S., Oslen M., et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003, 31:1312-1317.
12. Wip C., Napolitano L. Bundles to prevent ventilator-associated pneumonia: how valuable are they?. Curr Opin Infect Dis 2009, 22:159-166.
13. Metheny N., Clouse R., Chang Y., et al. Tracheobronchial aspiration of gastric contents in critically-ill tube fed patients: frequency, outcomes, and risk factors. Crit Care Med 2006, 34:1007-1015.
14. Torres A., Serra-Batlles J., Ros E., et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med 1992, 116:540-543.
15. Drakulovic M., Torres A., Bauer T., et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomized trial. Lancet 1999, 354(9193):1851-1858.
16. van Nieuwenhoven C., Vandenbroucke-Grauls C., van Tiel F., et al. Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia: a randomized study. Crit Care Med 2006, 34:396-402.
17. Dries D., McGonigal M., Malian M., et al. Protocol-driven ventilator weaning reduces use of mechanical ventilation, rate of early reintubation, and ventilator-associated pneumonia. J Trauma 2004, 56:943-951.
18. Girard T., Kress J., Fuchs B., et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled Trial): a randomized controlled trial. Lancet 2008, 371(9607):126-134.
19. Robertson T., Mann H., Hyzy R., et al. Multicenter implementation of a consensus-developed, evidence-based, spontaneous breathing trial protocol. Crit Care Med 2008, 36:2753-2762.
20. Cook D., Fuller H., Guyatt G., et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994, 330:377-381.
21. Huang J., Cao Y., Liao C., et al. Effect of histamine-2-receptor antagonists versus sucralfate on stress ulcer prophylaxis in mechanically ventilated patients: a meta-analysis of 10 randomized controlled trials. Crit Care 2010, 14:R145.
22. Hirsch D., Ingenito E., Goldhaber S., et al. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 1995, 274:335-337.
23. Cook D., Attia J., Weaver B., et al. Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients. J Crit Care 2000, 15:127-132.
24. Jellinek H., Krenn H., Oczenski W., et al. Influence of positive airway pressure on the pressure gradient for venous return in humans. J Appl Physiol 2000, 88:926-932.
25. Geerts W., Heit J., Clagett G., et al. Prevention of venous thromboembolism. Chest 2001, 119(Suppl 1):132S-175S.
26. Bergmans D., Bonten M., Gaillard C., et al. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 2001, 164:382-388.
27. Koeman M., van der Ven A., Hak E., et al. Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 2006, 173:1348-1355.
28. Kollef M., Skubas N., Sundt T., et al. A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. Chest 1999, 116:1339-1346.
29. Bouza E., Perez M., Munoz P., et al. Continuous aspiration of subglottic secretions in the prevention of ventilator-associated pneumonia in the postoperative period of major heart surgery. Chest 2008, 134:938-946.
30. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Healthcare Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 2002, 23:759-769.
31. Pittet D., Tarara D., Wenzel R.P. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994, 271:1598-1601.
32. Dimick J.B., Pelz R.K., Consunji R., et al. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001, 136:229-234.
33. Digiovine B., Chenoweth C., Watts C., et al. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999, 160:976-981.
34. Implement the central line bundle. Institute for Healthcare Improvement. Available at: Accessed May 10, 2011. http://www.ihi.org/IHI/Topics/CriticalCare/IntensiveCare/Changes/ImplementtheCentralLineBundle.htm.
35. Chittick P., Sherertz R.J. Recognition and prevention of nosocomial vascular device and related bloodstream infections in the intensive care unit. Crit Care Med 2010, 38(Suppl 8):S363-S372.
36. Earle A.S. The germ theory in America: antisepsis and asepsis (1867-1900). Surgery 1969, 65:508-522.
37. Goldmann D. System failure versus personal accountability-the case for clean hands. N Engl J Med 2006, 355:121-123.
38. Albert R.K., Condie F. Hand-washing patterns in medical intensive-care units. N Engl J Med 1981, 304:1465-1466.
39. Yilmaz G., Koksal I., Aydin K., et al. Risk factors of catheter-related bloodstream infections in parenteral nutrition catheterization. JPEN J Parenter Enteral Nutr 2007, 31:284-287.
40. Rosenthal V.D., Guzman S., Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control 2005, 33:392-397.
41. Jenner E.A., Fletcher B.C., Watson P., et al. Discrepancy between self-reported and observed hand hygiene behaviour in healthcare professionals. J Hosp Infect 2006, 63:418-422.
42. Doberneck R.C., Kleinman R. The surgical garb. Surgery 1984, 95:694-698.
43. Raad I.I., Hohn D.C., Gilbreath B.J., et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994, 15:231-238.
44. Mermel L.A., McCormick R.D., Springman S.R., et al. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991, 91(3B):197S-205S.
45. Hu K.K., Veenstra D.L., Lipsky B.A., et al. Use of maximal sterile barriers during central venous catheter insertion: clinical and economic outcomes. Clin Infect Dis 2004, 39:1441-1445.
46. Toledo-Pereyra L.H., Toledo M.M. A critical study of Lister's work on antiseptic surgery. Am J Surg 1976, 131:736-744.
47. Maki D.G., Ringer M., Alvarado C.J. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991, 338(8763):339-343.
48. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002, 136:792-801.
49. Goede M.R., Coopersmith C.M. Catheter-related bloodstream infection. Surg Clin North Am 2009, 89:463-474.
50. Goetz A.M., Wagener M.M., Miller J.M., et al. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998, 19:842-845.
51. Lorente L., Henry C., Martín M.M., et al. Central venous catheter-related infection in a prospective and observational study of 2,595 catheters. Crit Care 2005, 9:R631-R635.
52. Deshpande K.S., Hatem C., Ulrich H.L., et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005, 33:13-20.
53. Parienti J.J., Thirion M., Mégarbane B., et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008, 299:2413-2422.
54. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006, 355:2725-2732.
55. Berenholtz S.M., Pronovost P.J., Lipsett P.A., et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004, 32:2014-2020.
56. Cook D., Randolph A., Kernerman P., et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 1997, 25:1417-1424.
57. Cobb D.K., High K.P., Sawyer R.G., et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 1992, 327:1062-1068.
58. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
59. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32:858-873.
60. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
61. Marshall J.C., Dellinger R.P., Levy M. The Surviving Sepsis Campaign: a history and a perspective. Surg Infect (Larchmt) 2010, 11:275-281.
62. Jones A.E., Focht A., Horton J.M., et al. Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock. Chest 2007, 132:425-432.
63. Kortgen A., Niederprüm P., Bauer M., et al. Implementation of an evidence-based " standard operating procedure" and outcome in septic shock. Crit Care Med 2006, 34:943-949.
64. Ferrer R., Artigas A., Levy M.M., et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008, 299:2294-2303.
65. Bakker J., Coffernils M., Leon M., et al. Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest 1991, 99:956-962.
66. Weinstein M.P., Murphy J.R., Reller L.B., et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983, 5:54-70.
67. Blot F., Schmidt E., Nitenberg G., et al. Earlier positivity of central-venous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998, 36:105-109.
68. American Thoracic Society, Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
69. Ibrahim E.H., Sherman G., Ward S., et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146-155.
70. Iregui M., Ward S., Sherman G., et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002, 122:262-268.
71. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
72. Kollef M.H., Sherman G., Ward S., et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462-474.
73. Finfer S., Bellomo R., Boyce N., et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247-2456.
74. Schortgen F., Lacherade J.C., Bruneel F., et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001, 357(9260):911-916.
75. LeDoux D., Astiz M.E., Carpati C.M., et al. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000, 28:2729-2732.
76. Russell J.A., Walley K.R., Singer J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358:877-887.
77. Chamberlain D.J., Willis E.M., Bersten A.B. The severe sepsis bundles as processes of care: a meta-analysis. Aust Crit Care 2011, 24(4):229-243.
78. Hébert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999, 340:409-417.
79. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367.
80. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354:449-461.
81. Finfer S., Chittock D.R., Su S.Y., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297.
82. Sevransky J.E., Levy M.M., Marini J.J., et al. Mechanical ventilation in sepsis-induced acute lung injury/acute respiratory distress syndrome: an evidence-based review. Crit Care Med 2004, 32(Suppl 11):S548-S553.
83. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342:1301-1308.
84. Annane D., Sébille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871.
85. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358:111-124.
86. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709.
87. Abraham E., Laterre P.F., Garg R., et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005, 353:1332-1341.
88. Bratzler D.W. The surgical infection prevention and surgical care improvement projects: promises and pitfalls. Am Surg 2006, 72:1010-1016.
89. Fry D.E. Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures. Surg Infect (Larchmt) 2008, 9:579-584.
90. Bratzler D.W., Hunt D.R. The Surgical Infection Prevention and Surgical Care Improvement Projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006, 43:322-330.
91. Anderson D.J., Kaye K.S., Classen D., et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(Suppl 1):S51-S61.
92. National Quality Measures Clearinghouse. Surgical care improvement project: percent of surgery patients with perioperative temperature management. Available at: Accessed September 23, 2011. http://www.qualitymeasures.ahrq.gov/content.aspx%3Fid%3D27417%26search%3Dscip%2B10.
93. Rosenberger L.H., Politano A.D., Sawyer R.G. The Surgical Care Improvement Project and prevention of post-operative infection, including surgical site infection. Surg Infect (Larchmt) 2011, 12:163-168.
94. Classen D.C., Evans R.S., Pestotnik S.L., et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992, 326:281-286.
95. Weber W.P., Marti W.R., Zwahlen M., et al. The timing of surgical antimicrobial prophylaxis. Ann Surg 2008, 247:918-926.
96. Steinberg J.P., Braun B.I., Hellinger W.C., et al. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the trial to reduce antimicrobial prophylaxis errors. Ann Surg 2009, 250:10-16.
97. Nguyen N., Yegiyants S., Kaloostian C., et al. The Surgical Care Improvement Project (SCIP) initiative to reduce infection in elective colorectal surgery: which performance measures affect outcome?. Am Surg 2008, 74:1012-1016.
98. Hawn M.T., Itani K.M., Gray S.H., et al. Association of timely administration of prophylactic antibiotics for major surgical procedures and surgical site infection. J Am Coll Surg 2008, 206:814-821.
99. ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery. Am J Health Syst Pharm 1999, 56:1839-1888.
100. Nichols R.L., Condon R.E., Barie P.S. Antibiotic prophylaxis in surgery-2005 and beyond. Surg Infect (Larchmt) 2005, 6:349-361.
101. Mangram A.J., Horan T.C., Pearson M.L., et al. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999, 20:250-278.
102. Barie P.S. Modern surgical antibiotic prophylaxis and therapy-less is more. Surg Infect (Larchmt) 2000, 1:23-29.
103. DiPiro J.T., Cheung R.P., Bowden T.A., et al. Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg 1986, 152:552-559.
104. McDonald M., Grabsch E., Marshall C., et al. Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg 1998, 68:388-396.
105. Bratzler D.W., Houck P.M. Surgical Infection Prevention Guidelines Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004, 38:1706-1715.
106. Dellinger E.P. Adherence to Surgical Care Improvement Project measures: the whole is greater than the parts. Future Microbiol 2010, 5:1781-1785.
107. Zerr K.J., Furnary A.P., Grunkemeier G.L., et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997, 63:356-361.
108. Furnary A.P., Zerr K.J., Grunkemeier G.L., et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999, 67:352-362.
109. Lazar H.L., Chipkin S.R., Fitzgerald C.A., et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004, 109:1497-1502.
110. Carr J.M., Sellke F.W., Fey M., et al. Implementing tight glucose control after coronary artery bypass surgery. Ann Thorac Surg 2005, 80:902-909.
111. Leibowitz G., Raizman E., Brezis M., et al. Effects of moderate intensity glycemic control after cardiac surgery. Ann Thorac Surg 2010, 90:1825-1832.
112. Kjønniksen I., Andersen B.M., Søndenaa V.G., et al. Preoperative hair removal-a systematic literature review. AORN J 2002, 75:928-938.
113. Kurz A., Sessler D.I., Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. N Engl J Med 1996, 334:1209-1215.
114. Barone J.E., Tucker J.B., Cecere J., et al. Hypothermia does not result in more complications after colon surgery. Am Surg 1999, 65:356-359.
115. Walz J.M., Paterson C.A., Seligowski J.M., et al. Surgical site infection following bowel surgery: a retrospective analysis of 1446 patients. Arch Surg 2006, 141:1014-1018.
116. Lehtinen S.J., Onicescu G., Kuhn K.M., et al. Normothermia to prevent surgical site infections after gastrointestinal surgery: holy grail or false idol?. Ann Surg 2010, 252:696-704.
117. Dellinger E.P., Hausmann S.M., Bratzler D.W., et al. Hospitals collaborate to decrease surgical site infections. Am J Surg 2005, 190:9-15.
118. Pastor C., Artinyan A., Varma M.G., et al. An increase in compliance with the Surgical Care Improvement Project measures does not prevent surgical site infection in colorectal surgery. Dis Colon Rectum 2010, 53:24-30.
119. Berenguer C.M., Oschsner M.G., Lord S.A., et al. Improving surgical site infections: using national surgical quality improvement program data to institute surgical care improvement project protocols in improving surgical outcomes. J Am Coll Surg 2010, 210:737-743.
120. Larochelle M., Hyman N., Gruppi L., et al. Diminishing surgical site infections after colorectal surgery with surgical care improvement project: is it time to move on?. Dis Colon Rectum 2011, 54:394-400.
121. Ingraham A.M., Cohen M.E., Bilimoria K.Y., et al. Association of Surgical Care Improvement Project infection-related process measure compliance with risk-adjusted outcomes: implications for quality measurement. J Am Coll Surg 2010, 211:705-714.
122. Stulberg J.J., Delaney C.P., Neuhauser D.V., et al. Adherence to Surgical Care Improvement Project measures and the association with postoperative infections. JAMA 2010, 303:2479-2485.
123. Anthony T., Murray B.W., Sun-Ping J.T., et al. Evaluating an evidence-based bundle for preventing surgical site infection. A randomized trial. Arch Surg 2011, 146:263-269.
124. Snyder L., Neubauer R.L. Pay-for-performance principles that promote patient-centered care: an ethics manifesto. Ann Intern Med 2007, 147:792-794.